Tris Pharma issues voluntary nationwide recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, due to potential higher concentrations of ibuprofen: https://go.usa.gov/xPuHN.




Source